These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33928739)

  • 1. Antifibrinolytics reduces blood loss in thoracic surgery: a systematic review and meta-analysis.
    Leow L; Ng J; Luo HD; Choong AMTL; Mithiran H; Kofidis T; Tam JKC
    ANZ J Surg; 2021 Jun; 91(6):1251-1259. PubMed ID: 33928739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of aprotinin, tranexamic acid, and aminocaproic acid on blood loss and use of blood products in major pediatric surgery: a meta-analysis.
    Schouten ES; van de Pol AC; Schouten AN; Turner NM; Jansen NJ; Bollen CW
    Pediatr Crit Care Med; 2009 Mar; 10(2):182-90. PubMed ID: 19188875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical application of antifibrinolytic drugs for on-pump cardiac surgery: a systematic review and meta-analysis.
    Abrishami A; Chung F; Wong J
    Can J Anaesth; 2009 Mar; 56(3):202-12. PubMed ID: 19247741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.
    Later AF; Maas JJ; Engbers FH; Versteegh MI; Bruggemans EF; Dion RA; Klautz RJ
    Eur J Cardiothorac Surg; 2009 Aug; 36(2):322-9. PubMed ID: 19250838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of antifibrinolytic agents on surgical bleeding and transfusion requirements in spine surgery: a meta-analysis.
    Li G; Sun TW; Luo G; Zhang C
    Eur Spine J; 2017 Jan; 26(1):140-154. PubMed ID: 27671279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of antifibrinolytic agents in total hip arthroplasty: a meta-analysis.
    Gill JB; Rosenstein A
    J Arthroplasty; 2006 Sep; 21(6):869-73. PubMed ID: 16950041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transfusion requirements, morbidity and mortality in cardiac surgery and the use of antifibrinolytic agents: a comparison of aprotinin and tranexamic acid].
    Muedra V; Delás F; Villalonga V; Gómez M; Sánchez F; Llopis JE
    Rev Esp Anestesiol Reanim; 2011 Mar; 58(3):140-6. PubMed ID: 21534287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can we safely reduce blood loss during lumbar pedicle subtraction osteotomy procedures using tranexamic acid or aprotinin? A comparative study with controls.
    Baldus CR; Bridwell KH; Lenke LG; Okubadejo GO
    Spine (Phila Pa 1976); 2010 Jan; 35(2):235-9. PubMed ID: 20081519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of aprotinin and tranexamic acid on outcomes and cytokine profiles in neonates undergoing cardiac surgery.
    Graham EM; Atz AM; Gillis J; Desantis SM; Haney AL; Deardorff RL; Uber WE; Reeves ST; McGowan FX; Bradley SM; Spinale FG
    J Thorac Cardiovasc Surg; 2012 May; 143(5):1069-76. PubMed ID: 22075061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?
    Zufferey P; Merquiol F; Laporte S; Decousus H; Mismetti P; Auboyer C; Samama CM; Molliex S
    Anesthesiology; 2006 Nov; 105(5):1034-46. PubMed ID: 17065899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risks of harms using antifibrinolytics in cardiac surgery: systematic review and network meta-analysis of randomised and observational studies.
    Hutton B; Joseph L; Fergusson D; Mazer CD; Shapiro S; Tinmouth A
    BMJ; 2012 Sep; 345():e5798. PubMed ID: 22968722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifibrinolytics in major orthopaedic surgery.
    Eubanks JD
    J Am Acad Orthop Surg; 2010 Mar; 18(3):132-8. PubMed ID: 20190103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions.
    Casati V; Guzzon D; Oppizzi M; Bellotti F; Franco A; Gerli C; Cossolini M; Torri G; Calori G; Benussi S; Alfieri O
    J Thorac Cardiovasc Surg; 2000 Sep; 120(3):520-7. PubMed ID: 10962414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic Use of Antifibrinolytics During Pediatric Cardiac Surgery With Cardiopulmonary Bypass on Postoperative Bleeding and Transfusion: A Systematic Review and Meta-Analysis.
    Schertz K; Karam O; Demetres M; Mayadunna S; Faraoni D; Nellis ME
    Pediatr Crit Care Med; 2022 Nov; 23(11):e517-e529. PubMed ID: 35997516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination?
    Bulutcu FS; Ozbek U; Polat B; Yalçin Y; Karaci AR; Bayindir O
    Paediatr Anaesth; 2005 Jan; 15(1):41-6. PubMed ID: 15649162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural and synthetic antifibrinolytics in adult cardiac surgery: efficacy, effectiveness and efficiency.
    Hardy JF; Bélisle S
    Can J Anaesth; 1994 Nov; 41(11):1104-12. PubMed ID: 7530172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifibrinolytic therapy in complex spine surgery: a case-control study comparing aprotinin and tranexamic acid.
    Colomina MJ; Bagó J; Vidal X; Mora L; Pellisé F
    Orthopedics; 2009 Feb; 32(2):91. PubMed ID: 19301800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does perioperative use of aprotinin reduce the rejection rate in heart transplant recipients?
    Shuhaiber JH; Goldsmith K; Large SR; Tsui S
    Eur J Cardiothorac Surg; 2008 May; 33(5):849-55. PubMed ID: 18359637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aprotinin and tranexamic acid for high transfusion risk cardiac surgery.
    Wong BI; McLean RF; Fremes SE; Deemar KA; Harrington EM; Christakis GT; Goldman BS
    Ann Thorac Surg; 2000 Mar; 69(3):808-16. PubMed ID: 10750765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.